Brief: Bioarctic's Says As Per Eisai's Simulation Leqembi Sales Will Reach JPY 290 Bln For Financial Year 2026
March 7 (Reuters) - BioArctic AB BIOAb.ST :
* BIOARCTIC'S PARTNER EISAI PRESENTS UPDATED SALES
SIMULATION FOR
LEQEMBI® AT ITS ANNUAL PRESS CONFERENCE
* BIOARCTIC AB - LEQEMBI SALES WILL REACH JPY 290 BILLION
FOR
THEIR FINANCIAL YEAR (FY) 2026, WHICH ENDS IN MARCH 2027 AND JPY
1.6 TRILLION IN FY2032
Source text for Eikon: ID:nWkr5jtZSw
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million